Innovations

Focus on research: access here the latest developments in AF and EP medicine. Featuring news, conference highlights, late-breaking trials and the latest developments from industry.

Welcome and Current State of the Art in AF

    Welcome and Current State of the Art in AF

    New Horizons in AF was a scientific meeting which highlighted current approaches to the diagnosis and treatment of atrial fibrillation. The meeting hosted faculty from across the globe and each presenter shared their personalised AF therapy strategies. Access here a collection of key presentations from the meeting.

    View all

    Case Lab

    Focus on clinical: access here a wealth of tips and tricks from real-life case examples and case reports.

    Ablation of RV Outflow Tract Ectopic Originating Close to the His Bundle
    • Challenging Case

    Ablation of RV Outflow Tract Ectopic Originating Close to the His Bundle

    Catheter ablation of the right ventricular outflow tract (RVOT) premature ventricular depolarizations (VEs) is highly efficacious. However, VEs originating close to the His bundle is an uncommon form of RVOT-VEs, occurring in about 5% of all RVOT-VEs undergoing catheter ablation. Ablation carries a potential risk of damaging the conduction system. We describe a case of RVOT-VE, mapped by high-density electroanatomical mapping and electrocardiographic criteria, with the successful ablation site close to the His bundle. The methods to avoid heart block are discussed.

    View all

    Education

    Focus on training: access relevant content to develop your knowledge, learning and practice methods in EP.

    The CIRCA-DOSE trial
    • Journal Review: Focus on Europe

    The CIRCA-DOSE trial

    The pivotal CIRCA-DOSE study was a randomized study that examined the AF burden in detail and changed how we conceptualise study endpoints when it published in Circulation back in 2019. Dr Dhiraj Gupta (Liverpool, UK) meets with the principal investigator of the study, Dr Jason Andrade (Vancouver, CA), who presents the data behind the original CIRCA-DOSE study and discusses the results from the recent secondary analysis examining the clinical definition of AF, which has recently been published in JAMA Open. They close by discussing how this research might influence clinical practice going forwards.

    View all

    Editor in Chief

    Angelo Auricchio is Editor in Chief of Arrhythmia Academy, Director of the Clinical Electrophysiology Unity at the Fondazione Cardiocentre Ticino in Lugano, Switzerland and Professor of Cardiology at the University Hospital, Magdeburg, Germany. He is the past President of European Heart Rhythm Association (EHRA) and Scientific Director at the Fondazione Ticino Cuore, an institution devoted to increasing the public awareness of out-of-hospital cardiac arrest victims and to improve the survival rate of its victims.

    In 1991, he received the Young Investigator Award of the North American Society of Pacing and Clinical Electrophysiology, and in 2005 he received the Fritz Acker Award from the Germany Society of Cardiology for his research on cardiac resynchronization therapy. Dr Auricchio is also an inventor with 10 active patents and applications, the most relevant being a left ventricular pacing lead with an over-the-wire design; this lead represents today, the standard pacing technique for cardiac resynchronization therapy.

    Editorial Board

    • Luis Aguinaga
      Centro Privado de Cardiología, Tucuman, Argentina